Pladsen AV, Smebye ML, Garred Ø, Borgen E, Egeland EV, Haugen MH, Dahle MA, Prasmickaite L, Mælandsmo GM, Hovig E, Nakken S, Østgaard A, Bergheim IR, Reinertsen K, Ohnstad HO, Schlichting E, Skjerven HK, Dale AB, Wist E, Naume B, Russnes HG, Lingjærde OC, Engebraaten O (2026)
DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor Positive and Triple-Negative Breast Cancer
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-26-2212, PubMed 42870529

Azimzade Y, Haugen MH, Kristensen VN, Frigessi A, Köhn-Luque A (2026)
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-73617-9, PubMed 42185288

Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O (2025)
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy
Breast Cancer Res, 27 (1), 143
DOI 10.1186/s13058-025-02092-9, PubMed 40790765